Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OVM-200 |
Trade Name | |
Synonyms | OVM200|OVM 200 |
Drug Descriptions |
OVM-200 is a cancer vaccine comprised of peptides derived from survivin, which may induce cytotoxic T-lymphocyte (CTL)-mediated killing of tumor cells expressing survivin (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185161 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
OVM-200 | OVM-200 | 0 | 1 |